Tuesday, November 19, 2024
Registration and Breakfast, Yawkey 306-307
Opening Remarks
Panagiotis Konstantinopoulos, MD, PhD
Bytes to Beside: Mutational Signatures in BRCA1/BRCA2-Deficiency and Clinical Updates
Serena Nik-Zainal, PhD
How is Prevention in the Genes?
Fatima Karzai, MD
Homologous Recombination Licensing Role of BRCA1
Patrick Sung, DPhil
Lunch Break, Yawkey 306-307
Therapeutic Exploration of Homologous Recombination Deficient in Pancreatic Cancer
Talia Golan, MD
Homologous Recombination Deficiency in Prostate Cancer: Implications for Early Detection and Management of Localized Disease
Keyan Salari, MD, PhD
Developing Medicines to Exploit Novel and Mature DDR Targets
Ian Smith, MD
Resistance to HRD Targeting Agents
Chris Lord, PhD
Afternoon Break, Yawkey 306-307
Leveraging Epigenetics to Address Unmet Needs in BRCAness Ovarian Cancer
Rugang Zhang, PhD
PARPi/ADC Combinations
Elizabeth K. Lee, MD
Overcoming PARPi Resistance by Understanding BRCA1-Dependent and BRCA1-Independent HR
Yizhou He, PhD
Closing Remarks
Panagiotis Konstantinopoulos, MD, PhD